TL;DR
The Supreme Court affirmed the Court of Appeals’ decision, finding Prosel Pharmaceuticals’ brand ‘CEEGEEFER’ to be a colorable imitation of Tynor Drug House’s registered trademark ‘CHERIFER + Logo’. This means Prosel is legally prohibited from using the CEEGEEFER brand name and similar packaging due to trademark infringement. For businesses, this ruling underscores the importance of conducting thorough trademark clearance searches and creating distinctly different brand names and packaging to avoid consumer confusion and legal repercussions, especially in closely related product markets like over-the-counter vitamins.
When Brand Names Sound Alike: Navigating the Fine Line of Trademark Infringement
Can a brand name too similar in sound and appearance to an existing one constitute trademark infringement? This was the central question in the case of Prosel Pharmaceuticals & Distributors, Inc. v. Tynor Drug House, Inc., where the Supreme Court delved into the intricacies of trademark law. Tynor Drug House, the maker of ‘CHERIFER’ multivitamins, sued Prosel Pharmaceuticals for trademark infringement, claiming that Prosel’s ‘CEEGEEFER’ product, a children’s vitamin supplement, was confusingly similar to their registered ‘CHERIFER + Logo’ trademark. The dispute highlights the constant challenge businesses face in creating unique brand identities while operating in competitive markets, particularly in industries like pharmaceuticals where brand recognition is crucial.
Tynor Drug House had registered its ‘CHERIFER + Logo’ trademark in 2004, featuring the word ‘CHERIFER’ along with a logo of a boy playing basketball and the slogan ‘HEIGHT IS MIGHT’. Prosel Pharmaceuticals, on the other hand, introduced ‘CEEGEEFER’, a multivitamin product, claiming its name was derived from ‘Chlorella Growth Factor’ (CGF), an ingredient in the supplement. Tynor argued that CEEGEEFER’s name, logo, and packaging were so similar to CHERIFER’s that it constituted trademark infringement and unfair competition. They pointed to phonetic similarities between ‘CHERIFER’ and ‘CEEGEEFER’, and striking visual resemblances in packaging, including a basketball-playing boy, similar color schemes, and slogan arcs.
The legal framework for trademark infringement in the Philippines is primarily governed by the Intellectual Property Code (Republic Act No. 8293). Section 155.1 of this code specifies that trademark infringement occurs when someone uses “any reproduction, counterfeit, copy, or colorable imitation of a registered mark” in commerce, which is “likely to cause confusion, or to cause mistake, or to deceive.” The key element is the likelihood of confusion among consumers. To determine this, Philippine courts often employ two tests: the dominancy test, focusing on the dominant features of the marks, and the holistic or totality test, considering the overall impression of the marks.
In this case, the Supreme Court leaned heavily on the dominancy test, agreeing with the Court of Appeals that both ‘CHERIFER’ and ‘CEEGEEFER’ were phonetically similar, applying the principle of idem sonans (sounding alike). The Court cited previous cases where seemingly less similar-sounding names were deemed confusingly similar. Furthermore, the Court observed the striking visual similarities between the logos and packaging. Both featured a boy in a basketball jersey and cap, performing a dunk, with slogans in an arc above, and used orange and yellow color schemes. The Supreme Court stated:
As regards the logos used by the parties, the same are strikingly similar. A side by side comparison of the pictures in CHERIFER and CEEGEEFER show the right profile/side of a boy wearing a basketball jersey and a baseball cap shooting a basketball on a hoop with their knees slightly bent and with the words that start with the letters “H” and “M” on top in an arc that both have a different colored line in the middle. Note, too, that both packages use orange and yellow.
Prosel Pharmaceuticals argued minor differences in the logos and product composition, emphasizing that CEEGEEFER contained Vitamin C and CGF, while CHERIFER was just a multivitamin. They also claimed their target market (mothers purchasing for children) would not be confused. However, the Court dismissed these arguments, stressing that the crucial factor is the likelihood of confusion, not actual confusion, and that even over-the-counter products sold side-by-side in drugstores could lead to consumer mistake. The Court underscored Prosel’s prior admission of resemblance between the packaging in an earlier letter as further evidence of colorable imitation.
The dissenting opinion by Justice Leonen raised a critical point, arguing that the majority improperly dissected Tynor’s registered composite mark (‘CHERIFER + Logo’) by separately comparing ‘CEEGEEFER’ to ‘CHERIFER’ (word mark) and Prosel’s logo to the ‘HEIGHT IS MIGHT’ device, instead of assessing the overall similarity between the composite marks. The dissent also highlighted the lack of concrete evidence of actual consumer confusion or adverse impact on CHERIFER’s sales due to CEEGEEFER. Justice Leonen emphasized the importance of evidence-based standards for determining likelihood of confusion to avoid subjective judgments and undue restrictions on free trade. He argued that the ruling, in effect, granted Tynor a monopoly over elements of its composite mark beyond what was registered, potentially hindering fair competition.
Despite the dissent, the majority ruling prevailed, reinforcing the principle that trademark infringement can be found even without identical copying, especially when there is a colorable imitation that is likely to cause confusion in the minds of ordinary purchasers. This case serves as a potent reminder for businesses to exercise caution when developing brand names and packaging, especially in product categories where similar goods are sold to the same consumer base. Thorough trademark searches and creative differentiation are not merely best practices but legal necessities to protect brand identity and avoid costly legal battles.
FAQs
| What is trademark infringement? | Trademark infringement is the unauthorized use of a registered trademark or a confusingly similar mark in a way that is likely to cause consumer confusion about the source or origin of goods or services. |
| What is ‘colorable imitation’? | Colorable imitation refers to a close or ingenious imitation that is calculated to deceive ordinary persons, leading them to purchase one product believing it to be another due to resemblance to the original mark. |
| What are the ‘dominancy test’ and ‘holistic test’? | These are tests used by Philippine courts to assess likelihood of confusion. The dominancy test focuses on the similarity of dominant features of marks, while the holistic test considers the overall impression of the marks. |
| Why was ‘CEEGEEFER’ considered a colorable imitation of ‘CHERIFER’? | The court found ‘CEEGEEFER’ to be phonetically similar to ‘CHERIFER’ (idem sonans) and noted striking visual similarities in packaging, logos, color schemes, and slogans, leading to a likelihood of confusion. |
| What was the Supreme Court’s ruling? | The Supreme Court denied Prosel Pharmaceuticals’ petition, affirming the Court of Appeals’ decision that found Prosel liable for trademark infringement and enjoined them from using the ‘CEEGEEFER’ brand. Nominal damages were reduced to P100,000. |
| What is the practical implication of this case for businesses? | Businesses must conduct thorough trademark searches and ensure their brand names and packaging are distinctly different from existing registered marks, especially in related product categories, to avoid legal action for trademark infringement. |
For inquiries regarding the application of this ruling to specific circumstances, please contact Atty. Gabriel Ablola through gaboogle.com or via email at connect@gaboogle.com.
Disclaimer: This analysis is provided for informational purposes only and does not constitute legal advice. For specific legal guidance tailored to your situation, please consult with a qualified attorney.
Source: Prosel Pharmaceuticals & Distributors, Inc. v. Tynor Drug House, Inc., G.R. No. 248021, September 30, 2020